NIH Revised Review Process for Human Gene Transfer Protocols Subject to the NIH Guidelines for Research Involving Recombinant or Synthetic Nucleic Acid Molecules

NIH has changed its policy regarding Recombinant DNA Advisory Committee’s (RAC) review of individual human gene transfer trials.

Effective April 27, 2016, UCI’s Institutional Biosafety Committee will determine whether investigator-initiated research requires RAC review based on specific criteria.  The RAC Revision Factsheet includes a list of the criteria and a summary of the changes.  Also see the IBC and IRB related web pages for more information.